Channel Therapeutics

Channel Therapeutics

Pre-clinical
San Diego, United StatesFounded 2018channeltherapeutics.com

Breakthroughs that break through pain and addiction Channel Therapeutics is developing innovative non-addictive, drugs to treat chronic neuropathic and acute and chronic eye pain. Breakthroughs that break through pain and addiction Channel Therapeutics is developing innovative, non-addictive, drugs to treat chronic neuropathic and acute and chronic eye pain.

Founded
2018
Focus
Small Molecules

About

Breakthroughs that break through pain and addiction Channel Therapeutics is developing innovative non-addictive, drugs to treat chronic neuropathic and acute and chronic eye pain. Breakthroughs that break through pain and addiction Channel Therapeutics is developing innovative, non-addictive, drugs to treat chronic neuropathic and acute and chronic eye pain.

Funding History

2

Total raised: $18M

Series A$15MUndisclosedJun 15, 2023
Seed$3MUndisclosedJun 15, 2021

Company Info

TypePrivate
Founded2018
LocationSan Diego, United States
StagePre-clinical
SIMILAR COMPANIES
BASi Research Products
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
EydisBio
Pre-clinical · Cambridge
3Spine
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?

Claim your profile to update information, add pipeline data, and connect with investors.

Claim profile